Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9233144
APP PUB NO 20120034167A1
SERIAL NO

13062804

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns new methods for treating cancer by using TYRO3 inhibitors and methods for identifying new molecules of interest for treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3 RUE MICHEL-ANGE PARIS 75016
INSTITUT CURIE26 RUE D'ULM PARIS CEDEX 05 75248
UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE94000 CRÉTEIL
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3 AVENUE VICTORIA PARIS F-75004

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allory, Yves Paris, FR 5 2
Bernard-Pierrot, Isabelle Nogent sur Marne, FR 3 1
Radvanyi, Francois Fontenay aux Roses, FR 6 4
Stransky, Nicolas Le Kremlin Bicetre, FR 19 64

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00